Compare KZIA & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KZIA | GDO |
|---|---|---|
| Founded | 1994 | N/A |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.8M | 86.7M |
| IPO Year | 2002 | 2009 |
| Metric | KZIA | GDO |
|---|---|---|
| Price | $9.98 | $11.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $17.67 | N/A |
| AVG Volume (30 Days) | ★ 153.1K | 26.3K |
| Earning Date | 11-07-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.86 | $10.52 |
| 52 Week High | $17.40 | $12.15 |
| Indicator | KZIA | GDO |
|---|---|---|
| Relative Strength Index (RSI) | 68.55 | 59.23 |
| Support Level | $5.74 | $10.52 |
| Resistance Level | $10.92 | $11.81 |
| Average True Range (ATR) | 0.96 | 0.23 |
| MACD | 0.22 | 0.07 |
| Stochastic Oscillator | 76.10 | 70.55 |
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.